Seminars in Nuclear Medicine
Volume 35, Issue 2 , Pages 100-115 , April 2005

Clinical applications of 99mTc-sestamibi scintimammography

  • Raymond Taillefer, MD (FRCP(C), ABNM)

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Raymond Taillefer, MD, FRCP(C), ABNM, Department of Nuclear Medicine, Hotel-Dieu du CHUM, 3840 St-Urbain, Montréal H2W 1T8, Canada.

References 

  1. Parkin DM , Pisani P , Ferlay J . Global cancer statistics . CA Cancer J Clin . 1999;49:33–64
  2. Greenlee RT , Murray T , Bolden S , et al.   Cancer statistics, 2000 . CA Cancer J Clin . 2000;50:7–33
  3. Kopans DB . The positive predictive value of mammography . AJR Am J Roentgenol . 1992;158:521–526
  4. Pollei SR , Mettler FA , Bartow SA , et al.   Occult breast cancer (Prevalence and radiographic detectability) . Radiology . 1987;163:459–462
  5. Bassett LW , Liu TH , Giuliano AE , et al.   The prevalence of carcinoma in palpable versus impalpable, mammographically detected lesions . AJR Am J Roentgenol . 1991;157:21–24
  6. Tabar L , Fagerberg CJ , Duffy SW , et al.   The Swedish two county trial of mammographic screening for breast cancer (Recent results and calculation of benefit) . J Epidemiol Community Health . 1989;43:107–114
  7. Sickles EA . Mammographic features of early breast cancer . AJR Am J Roentgenol . 1984;143:461–464
  8. Niloff PH , Sheiner NM . False-negative mammograms in patients with breast cancer . Can J Surg . 1981;24:50–52
  9. Meyer JE , Sonnenfeld MR , Greenes RA , et al.   Preoperative localization of clinically occult breast lesions; experience at a referral hospital . Radiology . 1988;169:627–628
  10. Mann BD , Giuliano AE , Bassett LW , et al.   Delayed diagnosis of breast cancer as a result of normal mammograms . Arch Surg . 1983;118:23–25
  11. Addler DD , Wahl RL . New methods for imaging the breast (Techniques, Findings and potential) . AJR Am J Roentgenol . 1995;164:19–30
  12. Taillefer R . The role of 99mTc-sestamibi and other conventional radiopharmaceuticals in breast cancer diagnosis . Semin Nucl Med . 1999;29:16–40
  13. Ryan KP , Dillman RO , DeNardo SJ , et al.   Breast cancer imaging with In-111 human IgM monoclonal antibodies (Preliminary studies) . Radiology . 1988;167:71–75
  14. Kalofonos HP , Sackier JM , Hatzistylianou M , et al.   Kinetics, quantitative analysis and radioimmunolocalisation using indium-111-HMFG1 monoclonal antibody in patients with breast cancer . Br J Cancer . 1989;59:939–942
  15. Major P , Wang T , Ishida M , et al.   Breast cancer imaging with mouse monoclonal antibodies . Eur J Nucl Med . 1989;15:655–660
  16. Lamki LM , Buzdar AU , Singletary SE , et al.   Indium-111-labeled B72.3 monoclonal antibody in the detection and staging of breast cancer (A phase I study) . J Nucl Med . 1991;32:1326–1332
  17. Goldenberg DM , Larson SM . Radioimmunodetection in cancer identification . J Nucl Med . 1992;33:803–814
  18. Thor AD , Edgerton SM . Monoclonal antibodies reactive with human breast or ovarian carcinoma (in vivo applications) . Semin Nucl Med . 1989;19:295–308
  19. Rosner D , Nabi H , Wild L , et al.   Diagnosis of breast carcinoma with radiolabeled monoclonal antibodies (MoAbs) to carcinoembryonic antigen (CEA) and human milk fat globulin (HMFG) . Cancer Invest . 1995;13:573–582
  20. Granowska M , Biassoni L , Carroll MJ , et al.   Breast cancer 99mTc SM3 radioimmunoscintigraphy . Acta Oncol . 1996;35:319–321
  21. Abdel-Dayem HM , Scott AM , Macapinlac HA , et al.   Role of 201Tl chloride and 99mTc sestamibi in tumor imaging . In:  Freeman L editors. Nuclear Medicine Annual . New York, NY: Raven Press; 1994;p. 181–234
  22. Sehweil AM , McKillop JH , Milroy R , et al.   Mechanism of 201Tl uptake in tumours . Eur J Nucl Med . 1989;15:376–379
  23. Waxman AD , Ramanna L , Memsic LD , et al.   Thallium scintigraphy in the evaluation of mass abnormalities of the breast . J Nucl Med . 1993;34:18–23
  24. Taillefer R . Clinical applications of 99mTc-sestamibi scintimammography . Semin Breast Dis . 2002;5:128–141
  25. DeJong M , Bernard BF , Freeman WAP , et al.   Comparison of uptake of 99mTc-MIBI, 99mTc-Tetrofosmin and 99mTc-Q12 into human breast cancer line . Eur J Nucl Med . 1996;23:1361–1366
  26. Mansi L , Rambaldi PF , Cuccurullo V , et al.   Breast imaging with 99mTc-tetrofosmin . In:  Taillefer R ,  Khalkhali I ,  Waxman A ,  Biersack H editor. Radionuclide imaging of the breast . New York, NY: Marcel Dekker; 1998;p. 339–367
  27. Piccolo S , Lastoria S , Mainolio C , et al.   Technetium-99m-methylene diphosphonate scintimammography to image primary breast cancer . J Nucl Med . 1995;36:718–724
  28. Piccolo S , Lastoria S , Muto P , et al.   Scintimammography (SNM) with 99mTc-MDP (An overview of the experience at the National Cancer Institute of Napoli) . Tumori . 1997;83:515–519
  29. Lastoria S , Piccolo S , Muto P . Breast imaging with 99mTc-methylene-diphosphonate . In:  Taillefer R ,  Khalkhali I ,  Waxman A ,  Biersack H editor. Radionuclide Imaging of the Breast . New York, NY: Marcel Dekker; 1998;p. 299–323
  30. Muller ST , Guth-Tougelids B , Creutzig GH . Imaging of malignant tumors with Tc-99m MIBI SPECT . Eur J Nucl Med . 1987;28:562–565
  31. Hassan IM , Sehweil A , Constantinindes C , et al.   Uptake and kinetics of Tc-99m hexakis 2-methoxy isobutyl isonitrile in benign and malignant lesions in the lungs . Clin Nucl Med . 1989;14:333–340
  32. Aktolun C , Bayhan H , Kir M . Clinical experience with Tc-99m MIBI imaging in patients with malignant tumors (Preliminary results and comparison with T1-201) . Clin Nucl Med . 1992;17:171–176
  33. Chiu ML , Kronange JF , Piwnica-Worms D . Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2 methoxyisobutyl isonitrile) technetium in cultured mouse fibroblasts . J Nucl Med . 1990;31:1646–1653
  34. Delmon-Moingeon LI , Piwnica-Worms D , Van den Abbeele AD , et al.   Uptake of the cation hexakis (2-methoxy isobutylisonitrile)-technetium-99m by human carcinoma cell lines in vitro . Cancer Res . 1990;50:2148–2202
  35. Piwnica-Worms D , Chiu ML , Budding M , et al.   Functional imaging of multidrug resistant P-glycoprotein with an organotechnetium complex . Cancer Res . 1993;53:977–984
  36. Cordobes MD , Starzec A , Delmon-Moingeon L , et al.   Technetium-99m-sestamibi uptake by human benign and malignant breast tumor cells (Correlation with mdr gene expression) . J Nucl Med . 1996;37:286–289
  37. Moretti JL , Azaloux H , Boisseron D , et al.   Primary breast cancer imaging with technetium-99m sestamibi and its relation with P-glycoprotein overexpression . Eur J Nucl Med . 1996;23:980–986
  38. Crane PD , Onthank DC , Bourque CR , et al.   Autoradiography and radioscintigraphy of technetium-99m-sestamibi in c-neu transgenic mice . J Nucl Med . 1995;36:1862–1868
  39. Maublant J , Zheng Z , Rapp M , et al.   In vitro uptake of Tc-99m teboroxime in carcinoma cell lines and normal cell lines (Comparison with Tc99m sestamibi and Tl-201) . J Nucl Med . 1993;34:1949–1952
  40. Papantoniou V , Christodoulidou J , Papadaki E , et al.   Uptake and washout of 99mTcV-dimercaptosuccinic acid and 99mTc-sestamibi in the assessment of histological type and grade in breast cancer . Nuc Med Commun . 2002;23:461–467
  41. Khalkhali I , Mena I , Jouanne E , et al.   Prone scintimammography in patients with suspicion of carcinoma of the breast . J Am Coll Surg . 1994;178:491–497
  42. Lu G , Shih WJ , Huang HY , et al.   99mTc-MIBI mammoscintigraphy of breast masses (Early and delayed imaging) . Nucl Med Commun . 1995;16:150–156
  43. Burak Z , Argon M , Memi S . Evaluation of palpable breast masses with Tc99m MIBI (a comparative study with mammography and ultrasonography) . Nucl Med Commun . 1994;15:604–612
  44. Taillefer R , Robidoux A , Lambert R , et al.   Technetium-99m-sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement . J Nucl Med . 1995;36:1758–1765
  45. Paz A , Melloul M , Cytron S , et al.   The value of early and double phase 99mTc-sestamibi scintimammography in the diagnosis of breast cancer . Nucl Med Commun . 2000;21:341–348
  46. Nagaraj N , Waxman A , Ashok G , et al.   Comparison of SPECT and planar Tc-99m sestamibi (MIBI) imaging in patients with carcinoma of the breast . J Nucl Med . 1994;35:229–234
  47. Palmedo H , Schomburg A , Grunwald F , et al.   Technetium-99m-MIBI scintimammography for suspicious breast lesions . J Nucl Med . 1996;37:626–630
  48. Becherer A , Helbich T , Staudenherz A , et al.   The diagnostic value of planar and SPET scintimammography in different age groups . Nucl Med Comm . 1997;18:710–718
  49. Waxman AD . The role of 99mTc methoxyisobutylisonitrile in imaging breast cancer . Semin Nucl Med . 1997;27:40–54
  50. Kao C , Wang S , Liu T . The use of Tc99m methoxybutylisonitrile breast scintigraphy to evaluate palpable breast masses . Eur J Nucl Med . 1994;21:432–436
  51. Villanueva-Meyer J , Briscoe LJE , Cesani F , et al.   Mammoscintigraphy with technetium-99m-sestamibi in suspected breast cancer . J Nucl Med . 1996;37:926–930
  52. Mafioli L , Agresti R , Chiti A , et al.   Prone scintimammography in patients with non-palpable breast lesions . Anticancer Res . 1996;16:1269–1274
  53. Clifford EJ , Lugo-Zamudio C . Scintimammography in the diagnosis of breast cancer . Am J Surg . 1996;172:483–486
  54. Carril JM , Gomez0Barquin R , Quirce R , et al.   Contribution of 99mTc-MIBI scintimammography to the diagnosis of non-palpable breast lesions in relation to mammographic probability of malignancy . Anticancer Res . 1997;17:1677–1681
  55. Buscombe JR , Cwikla JB , Thakrar DS , et al.   Uptake of Tc-99m MIBI related to tumor size and type . Anticancer Res . 1997;17:1693–1694
  56. Ambrus E , Rajtar M , Ormandi K , et al.   Value of 99mTc MIBI and 99mTc(V) DMSA scintigraphy in evaluation of breast mass lesions . Anticancer Res . 1997;17:1599–1605
  57. Chen SL , Yin YQ , Chen JX , et al.   The usefulness of Technetium-99m-MIBI scintimammography in diagnosis of breast cancer (Using surgical histopathologic diagnosis as the gold standard) . Anticancer Res . 1997;27:1695–1698
  58. Scopinaro F , Schillaci O , Ussof W , et al.   A three center study on the diagnostic accuracy of 99mTc-MIBI scintimammography . Anticancer Res . 1997;17:1631–1634
  59. Tiling R , Khalkhali I , Sommer H , et al.   Role of technetium-99m sestamibi scintimammography and contrast-enhanced magnetic resonance imaging for the evaluation of indeterminate mammograms . Eur J Nucl Med . 1997;24:1121–1129
  60. Helbich TH , Becherer A , Trattnig S , et al.   Differentiation of benign and malignant breast lesions (MR imaging versus Tc-99m sestamibi scintimammography) . Radiology . 1997;202:412–429
  61. Collela AC , Scopinaro F , Schillaci O , et al.   99mTc-sestamibi breast scintigraphy . Tumori . 1997;83:520–522
  62. Mekhmandarov S , Sandbank J , Cohen M , et al.   Technetium-99m-MIBI scintimammography in palpable and nonpalpable breast lesions . J Nucl Med . 1998;39:86–91
  63. Cwikla JB , Buscombe JR , Kelleher SM , et al.   Comparison of accuracy of scintimammography and X-ray mammography in the diagnosis of primary breast cancer in patients selected for surgical biopsy . Clin Radiol . 1998;53:274–280
  64. Tiling R , Khalkhali I , Sommer H , et al.   Limited value of scintimammography and contrast-enhanced MRI in the evaluation of microcalcification detected by mammography . Nucl Med Commun . 1998;19:55–62
  65. Tolmos J , Cutrone JA , Wang B , et al.   Scintimammographic analysis of nonpalpable breast lesions previously identified by conventional mammography . J Nat Cancer Inst . 1998;90:846–849
  66. Flanagan DA , Gladding SB , Raymer Lovell F . Can scintimammography reduce unnecessary biopsies? . Am Surg . 1998;64:670–673
  67. Danielsson R , Boné B , Gad A , et al.   Sensitivity and specificity of planar scintimammography with 99mTc-sestamibi . Acta Radiol . 1999;40:394–399
  68. Howarth D , Sillar R , Clark D , et al.   Technetium-99m sestamibi scintimammography (the influence of histopathological characteristics, lesion size and the presence of carcinoma in situ in the detection of breast carcinoma) . Eur J Nuc Med . 1999;26:1475–1481
  69. Melloul M , Paz A , Ohana G , et al.   Double-phase 99mTc-sestamibi scintimammography and trans-scan in diagnosing breast cancer . J Nucl Med . 1999;40:376–380
  70. Horne T , Pappo I , Cohen-Pour M , et al.   99mTc-tetrofosmin scintimammography for detecting breast cancer; a comparative study with 99mTc-mibi . Nucl Med Commun . 2001;22:807–811
  71. Lumachi F , Ferretti G , Povolato M , et al.   Accuracy of technetium-99m sestamibi scintimammography and x-ray mammography in premenopausal women with suspected breast cancer . Eur J Nuc Med . 2001;28:1776–1780
  72. Alonso O , Massardo T , Delgado LB , et al.   Is 99mTc-sestamibi scintimammography complementary to conventional mammography for detecting breast cancer in patients with palpable masses? . J Nucl Med . 2001;42:1614–1621
  73. Lumachi F , Ferretti G , Povolato M , et al.   Usefulness of 99mTc-sestamibi scintimammography in suspected breast cancer and in axillary lymph node metastases detection . Eur J Surg Oncol . 2001;27:256–269
  74. Sun SS , Hsieh JF , Tsai SC , et al.   The role of technetium-99m methoxyisobutylisonitrile scintimammography in diagnosis of breast cancer in patients with mammographically dense breasts . Anticancer Res . 2000;20:3755–3758
  75. Khalkhali I , Baum JK , Villanueva-Meyer J , et al.   99mTc-sestamibi breast imaging for the examination of patients with dense and fatty breasts (multicenter study) . Radiology . 2002;222:149–155
  76. Leidenius MHK , Leppanen EA , Tykka HT , et al.   The role of Tc99m-sestamibi scintimammography in combination with the triple assessment of primary breast cancer . Eur J Surg Oncol . 2002;28:108–112
  77. Lumachi F , Zucchetta P , Marzola MC , et al.   Positive predictive value of 99mTc-sestamibi scintimammography in patients with nonpalpable, mammographically detected, suspicious, breast lesions . Nuc Med Commu . 2002;23:1073–1078
  78. Sampalis FS , Denis R , Picard D , et al.   International prospective evaluation of scintimammography with 99mTc-sestamibi . Am J surg . 2003;185:544–549
  79. Boné B , Kristoffersen Wiberg M , Szabo BK , et al.   Comparison of 99mTc-sestamibi scintimammography and dynamic MR imaging as adjuncts to mammography in the diagnosis of breast cancer . Acta Radiol . 2003;44:28–34
  80. Krishnaiah G , Sher-Ahmed A , Ugwu-Dike M , et al.   Technetium-99m sestamibi scintimammography complements mammography in the detection of breast cancer . Breast J . 2003;9:288–294
  81. Campeau RJ , Kronemer KA , Sutherland CM . Concordant uptake of Tc-99m sestamibi and Tl-201 in unsuspected breast tumor . Clin Nucl Med . 1992;12:936–937
  82. Chiti A , Mafioli L , Castellani M , et al.   Case report (technetium-99m-hexakis-2-methoxy-isobutyl-isonitrile imaging of breast cancer and myocardial infarction in the same patient) . Tumori . 1994;6:480–481
  83. Omar AM , Higazy E , Hussein S , et al.   Abnormal extracardiac uptake of 99mTc-sestamibi, accidental findings in myocardial perfusion tomography . Radiologia Diagnostica . 1993;34:364–365
  84. Albertini JJ , Lyman GH , Cox C , et al.   Lymphatic mapping and sentinel node biopsy in the patient with breast cancer . JAMA . 1996;276:1818–1822
  85. Vargas HI , Vargas MP , Khalkhali I . Breast lymphoscintigraphy and sentinel node biopsy . Semin Breast Dis . 2002;5:156–172
  86. Taillefer R . Breast scintigraphy . In:  Ell PJ ,  Ghambir SS editor. Nuclear Medicine in Clinical Diagnosis and Treatment . (ed 3). New York, NY: Churchill Livingstone; 2004;p. 175–194
  87. Lam WWM , Yang WT , Chan YL , et al.   Detection of axillary lymph node metastases in breast carcinoma by technetium-99m sestamibi breast scintigraphy, ultrasound and conventional mammography . Eur J Nucl Med . 1996;23:498–503
  88. Schillaci O , Scopinaro F , Danieli R , et al.   Technetium-99m sestamibi imaging in the detection of axillary lymph node involvement in patients with breast cancer . Anticancer Res . 1997;17:1607–1610
  89. Perre CI , Rutter JE , Vos PFM , et al.   Technetium-99m-sestamibi uptake in axillary lymph node metastases in breast cancer patients . Eur J Surg Oncol . 1997;23:142–144
  90. Chiti A , Maffioli LS , Agresti R , et al.   Axillary node metastasis detection in breast cancer with 99mTc-sestamibi and 111In-pentetreotide . Tumori . 1997;83:537–538
  91. Taillefer R , Robidoux A , Turpin S , et al.   Metastatic axillary lymph node technetium-99m MIBI imaging in primary breast cancer . J Nucl Med . 1989;39:459–464
  92. Sun SS , Hsieh JF , Tsai SC , et al.   The role of technetium-99m methoxyisobutylisonitrile scintimammography in diagnosis of breast cancer in patients with mammographically dense breasts . Anticancer Res . 2000;20:3755–3758
  93. Babuccu O , Peksoy I , Kargi E , et al.   The value of scintimammography in reduction mammaplasties (A preliminary study) . Aesth Plast Surg . 2003;27:296–300
  94. Derebek E , Balci P , Alanyali H , et al.   Detection of bilateral multifocal breast cancer using Tc-99m sestamibi imaging . Clin Nucl Med . 1999;24:590–593
  95. Feldman LD , Hortobagyi GN , Buzdar AU , et al.   Pathological assessment of response to induction chemotherapy in breast cancer . Cancer Res . 1986;46:2578–2581
  96. Mankoff DA , Dunnwald LK , Gralow JR , et al.   Monitoring the response of patients with locally advanced breast carcinoma to neoadjuvant chemotherapy using technetium-99m-sestamibi scintimammography . Cancer . 1999;85:2410–2423
  97. Tiling R , Linke R , Untch M , et al.   18F-FDG PET and 99mTc-sestamibi scintimammography for monitoring breast cancer response to neoadjuvant chemotherapy (A comparative study) . Eur J Nucl Med . 2001;28:711–720
  98. Cayre A , Cachin F , Maublant J , et al.   Single static view 99mTc-sestamibi scintimammography predicts response to neoadjuvant chemotherapy and is related to MDR expression . Int J Oncol . 2002;20:1049–1055
  99. Hibbeln JF , Blend MJ , Wood DK . Tc-99m sestamibi uptake in infiltrating ductal carcinoma of the breast in a male patient . Clin Nucl Med . 1996;21:469–470
  100. Ohta H , Kosumi T , Kitai T , et al.   Three patients with bilateral breast tumors examined by technetium-99m-sestamibi scintimammography . Ann Nucl Med . 1997;11:259–262
  101. De Vincentis G , Scopinaro F , Pani R , et al.   99mTc-MIBI scintimammography with a high resolution single tube gamma camera (Preliminary study) . Anticancer Res . 1997;17:1627–1630
  102. Khalkhali I , Mishkin FS , Diggles LE , et al.   Radionuclide-guided stereotactic prebiopsy localization of nonpalpable breast lesions with normal mammograms . J Nucl Med . 1997;38:1019–1023
  103. Hillner BE . Decision analysis (MIBI imaging of non palpable breast abnormalities) . J Nucl Med . 1997;38:1772–1778
  104. Allen MW , Hendi P , Bassett L , et al.   A study on the cost effectiveness of sestamibi scintimammography for screening women with dense breasts for breast cancer . Breast Cancer Res and Treat . 1999;55:243–258
  105. Allen MW , Hendi P , Schwimmer J , et al.   Decision analysis for the cost effectiveness of sestamibi scintimammography in minimizing unnecessary biopsies . Q J Nucl Med . 2000;44:168–185
  106. Chen YS , Wang WH , Chan T , et al.   A review of the cost-effectiveness of Tc-99m sestamibi scintimammography in diagnosis of breast cancer in Taiwanese women with indeterminate mammographically dense breast . Surg Oncol . 2002;11:151–155

PII: S0001-2998(04)00074-1

doi: 10.1053/j.semnuclmed.2004.11.002

Seminars in Nuclear Medicine
Volume 35, Issue 2 , Pages 100-115 , April 2005

Article Tools

* Image Usage & Resolution